| | 57966-95-7 Basic information More.. |
| Product Name: | Cymoxanil | | Synonyms: | MANEX C-8;CIMOXPRON;CYMOXANIL;CURZATE;CURZATE(R);DPX 3217;cymoxyanil;dpx3217m | | CAS: | 57966-95-7 | | MF: | C7H10N4O3 | | MW: | 198.18 | | EINECS: | 261-043-0 | | Mol File: | 57966-95-7.mol |  |
Use
Technical cymoxanil has low acute toxicity. The acute oral LD50 is 960 mg/kg in rats. The acute dermal LD50 is 2,000 mg/kg in rabbits. The 4-hour rat inhalation LC50 is 5.06 mg/L. Minimal transient irritation of the skin and eyes was observed in rabbits. Cymoxanil did not cause skin sensitization in guinea pigs. Cymoxanil should be classified as Toxicity Category III for oral and dermal toxicity and Toxicity Category IV for inhalation toxicity and skin and eye irritation potential.
Absorption, Distribution and Excretion
Cymoxanil is rapidly absorbed and maximum concentrations in the blood and plasma is reached within 4 hours after dosing. Rapid and almost complete elimination of the administered radioactive dose was observed in urine and feces within 48 hours. Excretion is primarily by urine (64-75%), fecal (16-24%) and expired air ( 5%) of the administered dose. There is no significant difference in residue profiles or elimination rates between sexes, dose levels, or single or multiple dosing. No evidence of bioaccumulation was detected. DPX-T3217 is metabolized extensively and only trace level of the administered (14)C-cymoxanil was detected in the urine and feces.
- Cymoxanil
-
- US $0.00-0.00 / Kg
- 2024-04-10
- CAS:57966-95-7
- Min. Order: 1Kg
- Purity: 99.99%
- Supply Ability: 20 tons
- Cymoxanil
-
- US $0.00 / KG
- 2023-06-20
- CAS:57966-95-7
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
- Cymoxanil
-
- US $10.00 / KG
- 2021-08-14
- CAS:57966-95-7
- Min. Order: 100KG
- Purity: 99
- Supply Ability: 100 mt
|
|
57966-95-7
Recommend Suppliers |
|